Skip to main content
. 2000 Jan 4;97(1):483–488. doi: 10.1073/pnas.97.1.483

Figure 3.

Figure 3

Urine output and sodium, potassium, and cGMP excretion in CRH (5 μg)-treated rats in the absence or presence of two doses (2 and 10 μg) of the AVP receptor antagonist. Values are expressed as means ± SEM. *, P < 0.001 CRH-treated rats vs. controls (n = 14). **, P < 0.01 AVP antagonist-treated animals vs. CRH.